Código QR

Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors

Introduction Inflammatory arthritis (IA) conditions, including rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis, are characterised by inflammatory infiltration of the joints. Biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic disease-modifying anti...

Descrición completa

Gardado en:
Detalles Bibliográficos
Principais autores: Robin Christensen, Lars Erik Kristensen, Daniel Furst, Torkell Ellingsen, Sabrina Mai Nielsen, Simon Tarp, Esben Malm, Johannes Berg, John P. A. Ioannidis, Josef S. Smolen, Peter C. Taylor
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2021-09-01
Series:BMJ Open
Acceso en liña:https://bmjopen.bmj.com/content/11/9/e049850.full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!